Richard A Feelders
Overview
Explore the profile of Richard A Feelders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
4629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isand K, Arima H, Bertherat J, Dekkers O, Feelders R, Fleseriu M, et al.
Eur J Endocrinol
. 2025 Feb;
192(3):R17-R27.
PMID: 39973025
The objective of this study was to establish recommendations for thromboprophylaxis in patients with endogenous Cushing's syndrome (CS), addressing the elevated risk of venous thromboembolism (VTE) associated with hypercortisolism. A...
2.
Fleseriu M, Pivonello R, Newell-Price J, Gadelha M, Biller B, Auchus R, et al.
Pituitary
. 2025 Jan;
28(1):22.
PMID: 39863744
Purpose: To evaluate the effect of osilodrostat and hypercortisolism control on blood pressure (BP) and glycemic control in patients with Cushing's disease. Methods: Pooled analysis of two Phase III osilodrostat...
3.
Vietor C, Schurink I, Grunhagen D, Verhoef C, Franssen G, Feelders R, et al.
Endocr Relat Cancer
. 2024 Dec;
32(2).
PMID: 39652308
Up to 30% of adrenocortical carcinoma (ACC) patients have metastasised disease upon initial presentation, and systemic treatments currently fail to sufficiently improve survival. Palliative primary tumour resection can be considered...
4.
Vietor C, van Egmond I, Franssen G, Verhoef C, Feelders R, van Ginhoven T
Updates Surg
. 2024 Dec;
77(1):183-191.
PMID: 39643845
Adrenal masses are being found more and more often over the years. Given the association of these masses with advancing age, the decision to perform surgery in older, sometimes asymptomatic...
5.
Mulders M, Van Koetsveld P, Feelders R, Hofland L, de Herder W, Kraaij R, et al.
Endocr Relat Cancer
. 2024 Dec;
32(2.
PMID: 39635985
Midgut neuroendocrine tumors (NET) derive from enterochromaffin cells, which have a close interrelationship with intestinal microbiota. Recently, we have utilized 16S rRNA sequencing to uncover that midgut NET patients have...
6.
Newell-Price J, Fleseriu M, Pivonello R, Feelders R, Gadelha M, Lacroix A, et al.
J Endocr Soc
. 2024 Nov;
9(1):bvae201.
PMID: 39610378
Purpose: To assess whether simultaneous normalization of late-night salivary cortisol (LNSC) and mean urinary free cortisol (mUFC) in patients with Cushing disease treated with osilodrostat is associated with better clinical...
7.
Katragadda A, Kunadia J, Kirsch P, Dorcely B, Shah S, Henig Z, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13466.
PMID: 39506264
The neurocognitive and psychiatric effects of Cushing's syndrome (CS) are well recognized and negatively impact quality of life. The aim of this systematic review is to compare neurocognitive disease, psychiatric...
8.
Agrawal N, Urwyler S, Mehta S, Karavitaki N, Feelders R
Eur J Endocrinol
. 2024 Sep;
191(3):R37-R54.
PMID: 39276376
The first-line treatment for Cushing's disease is transsphenoidal adenomectomy, which can be curative in a significant number of patients. The second-line options in cases of failed primary pituitary surgery include...
9.
Xu K, Langenhuijsen J, Vietor C, Feelders R, van Ginhoven T, Elhassan Y, et al.
Eur J Endocrinol
. 2024 Aug;
191(3):345-353.
PMID: 39171965
Objective: Hereditary pheochromocytoma (hPCC) commonly develops bilaterally, causing adrenal insufficiency when standard treatment, radical adrenalectomy (RA), is performed. Partial adrenalectomy (PA) aims to preserve adrenal function, but with higher recurrence...
10.
Paes T, Feelders R, Hofland L
J Clin Endocrinol Metab
. 2024 Mar;
109(6):e1424-e1433.
PMID: 38517306
In Cushing syndrome (CS), prolonged exposure to high cortisol levels results in a wide range of devastating effects causing multisystem morbidity. Despite the efficacy of treatment leading to disease remission...